Home > Result Summaries: Compounds > SRT2104 > Result Summary for 113312

Result Summary for 113312

Result Summary

Protocol ID:	113312
Clinical Study ID:	SIR113312
Official Title:	A Randomized, Placebo-Controlled, Double-Blind, Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
Phase:	phase 1
Study Indications or Diseases:	Atrophy, Muscular
Generic Name:	SRT2104
Trade/Product Name:	SRT2104
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Vincenzo Libri1a, AndreLibri V ,Brown A, Gambarota G,Haddad J, Shields G, Dawes H, Pinato D,Hoffman E, Elliot P,Vlasuk G,Jacobson E,Wilkins M, Matthews P. Safety, pharmacokinetic and pharmacodynamic properties of a novel SIRT1 activator (SRT2104) in healthy elderly volunteers. PLoS ONE 7(12): e51395. 2012;7(12):e51395.